|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 639.50 INR | -1.81% |
|
+35.12% | +44.90% |
| 05-22 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-22 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 45.86B 480M 420M 388M 359M 681M 692M 4.64B 1.82B 22.52B 1.8B 1.76B 78B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 47.96B 502M 440M 405M 375M 712M 724M 4.85B 1.9B 23.55B 1.89B 1.85B 81.58B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.71% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -1.81% | ||
| 1 week | +35.12% | ||
| Current month | +37.70% | ||
| 1 month | +45.54% | ||
| 3 months | +88.45% | ||
| 6 months | +53.76% | ||
| Current year | +44.90% |
| 1 week | 455.3 |  | 685.95 |
| 1 month | 424.6 | | 685.95 |
| Current year | 280 | | 685.95 |
| 1 year | 280 | | 685.95 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 07/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 21/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 09/08/2023 |
| Director/Board Member | 57 | 09/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.81% | +35.12% | +6.87% | +67.26% | 480M | |
| +0.09% | +0.25% | +54.65% | +169.19% | 1,085B | |
| -1.63% | -1.50% | +65.79% | +62.70% | 624B | |
| -1.12% | -4.27% | +31.10% | +84.44% | 442B | |
| +0.85% | -0.59% | +28.75% | +27.65% | 332B | |
| -1.69% | -8.94% | +23.88% | +29.31% | 277B | |
| +0.52% | -2.33% | +25.93% | +45.65% | 282B | |
| +0.31% | -1.62% | -29.40% | -39.42% | 217B | |
| -1.19% | -2.81% | +22.63% | +66.30% | 196B | |
| -0.72% | +2.72% | +19.07% | +81.19% | 167B | |
| Average | -0.39% | +2.38% | +24.93% | +59.43% | 362.24B | |
| Weighted average by Cap. | +0.10% | -1.05% | +38.32% | +85.10% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 221M 193M 178M 165M 313M 319M 2.14B 838M 10.37B 830M 812M 35.91B | 22.02B 231M 202M 186M 172M 327M 332M 2.23B 874M 10.81B 866M 847M 37.45B |
| Net income | 1.38B 14.41M 12.6M 11.62M 10.75M 20.41M 20.75M 139M 54.56M 675M 54.09M 52.92M 2.34B | 2.53B 26.49M 23.17M 21.37M 19.77M 37.53M 38.15M 256M 100M 1.24B 99.44M 97.29M 4.3B |
| Net Debt | 3.7B 38.78M 33.93M 31.29M 28.95M 54.94M 55.86M 375M 147M 1.82B 146M 142M 6.3B | 2.11B 22.07M 19.31M 17.8M 16.47M 31.27M 31.79M 213M 83.58M 1.03B 82.86M 81.06M 3.58B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | ₹639.50 | -1.81% | 80,251 |
| 09/07/26 | ₹651.30 | +13.93% | 685,158 |
| 08/07/26 | ₹571.65 | +19.99% | 184,079 |
| 07/07/26 | ₹476.40 | +2.66% | 24,451 |
| 06/07/26 | ₹464.05 | -1.95% | 3,294 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
